ROIV
Roivant Sciences Ltd. · Healthcare
Director Keith S Manchester sold $5.9M of Roivant Sciences Ltd.
Sold$5,866,308
$11.66Price
503,000Shares
−28%Stake
What ROIV did after the filing
- The stock from Fri, Sep 27 open, $11.56
- +2.7%
- S&P 500, same days
- +4.3%
Measured over 30 trading days, to the Nov 8 close.
Traded Tue, Sep 24. Filed Thu, Sep 26, 4:35 PM ET, after the close. Returns use the Sep 27 open and the Nov 8 close. Not investment advice.